SS Innovations International Appoints Sarah M. Romano as CFO Amid Global Robotic Surgery Expansion

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has appointed veteran medical technology finance executive Sarah M. Romano as chief financial officer, adding public-company financial and capital markets experience as the surgical robotics developer continues its global expansion and advances regulatory initiatives. The appointment, effective August 3, comes at a time when SS Innovations is pursuing broader commercialization of its SSi Mantra robotic surgical platform while continuing preparations for U.S. Food and Drug Administration review (https://nnw.fm/yY4UM).

Romano joins SS Innovations after serving as chief financial officer at Vicarious Surgical, another developer of robotic surgical technologies, where she oversaw financial and operational initiatives designed to reduce cash burn, strengthen the company’s balance sheet and support growth. She brings more than two decades of experience in public-company finance, capital markets, and medical technology, having raised more than $100 million during her career. Her expertise will be pivotal as SS Innovations scales its operations and navigates the capital-intensive process of bringing a new surgical robot to market.

The company recently graduated the inaugural class of its SS International Centre for Robotics Surgery (“SSICRS”) cardiac robotic surgery training program. SSICRS welcomed 33 healthcare professionals from seven countries, underscoring the company’s emphasis on surgeon education alongside technology deployment. This training initiative is critical for ensuring that surgeons worldwide are proficient in using the SSi Mantra system, which is designed to make robotic surgery more accessible and affordable. By investing in education, SS Innovations aims to accelerate adoption and build a strong foundation for its global expansion.

The SSi Mantra is a modular robotic surgical system that has already received regulatory approvals in several countries, including India, where it has been used in hundreds of procedures. The company’s pursuit of FDA clearance in the United States represents a significant milestone, as it would open the world’s largest healthcare market. Romano’s appointment signals a strategic push to strengthen financial management and investor confidence during this critical phase.

SS Innovations is also expanding its international footprint. The company has established partnerships and distribution agreements in regions such as the Middle East, Africa, and parts of Asia. The focus on training and education, combined with a modular design that reduces costs, positions SS Innovations to compete with established players like Intuitive Surgical’s da Vinci system. The company’s latest news and updates are available in its newsroom at https://ibn.fm/SSII.

With Romano at the financial helm, SS Innovations is poised to navigate the complexities of regulatory approvals, global commercialization, and capital management. Her track record in raising capital and optimizing financial operations will be instrumental as the company seeks to bring its robotic surgical technology to more patients and healthcare providers worldwide. The implications of these developments extend beyond SS Innovations; they signal a broader shift in the surgical robotics landscape toward more accessible and cost-effective solutions.